Trial Profile
Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Argatroban (Primary) ; Danaparoid sodium (Primary) ; Fondaparinux sodium (Primary) ; Lepirudin (Primary)
- Indications Embolism and thrombosis; Heparin-induced thrombocytopenia and thrombosis syndrome
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 28 Nov 2017 Results published in the Journal of the American College of Cardiology
- 04 Mar 2011 New trial record